Krystal Biotech, Inc. (KRYS) Ownership

$221.96

$4.5 (2.07%)
Last update: 04:00 PM EST
Day's range
$213.83
Day's range
$222.66

Krystal Biotech, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 4.34 M $766.40 M   0.15% 15.02%
BLACKROCK, INC. 11/12/2025 3.83 M $676.84 M   -0.29% 13.26%
VANGUARD GROUP INC 11/07/2025 2.79 M $492.91 M   -1.09% 9.66%
AVORO CAPITAL ADVISORS LLC 11/14/2025 2.78 M $490.36 M   4.43% 9.61%
STATE STREET CORP 11/14/2025 1.40 M $246.43 M   3.00% 4.83%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 1.02 M $179.85 M   10.39% 3.52%
CAPITAL WORLD INVESTORS 11/13/2025 809.24 K $142.86 M   -14.12% 2.80%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/14/2025 688.46 K $121.53 M   0.00% 2.38%
REDMILE GROUP, LLC 11/14/2025 661.39 K $116.75 M   -0.31% 2.29%
CITADEL ADVISORS LLC 11/14/2025 636.99 K $112.45 M   1,743.14% 2.20%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 611.24 K $107.92 M   -1.34% 2.11%
HOOD RIVER CAPITAL MANAGEMENT LLC 11/14/2025 606.95 K $107.14 M   13.87% 2.10%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 533.96 K $94.26 M   5.55% 1.85%
BRAIDWELL LP 11/14/2025 520.40 K $91.87 M   -28.50% 1.80%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 467.06 K $82.45 M   78.69% 1.62%
GOLDMAN SACHS GROUP INC 11/14/2025 348.25 K $61.48 M   -34.34% 1.20%
FIRST TRUST ADVISORS LP 11/12/2025 248.39 K $43.85 M   11.70% 0.86%
NORTHERN TRUST CORP 11/14/2025 248.17 K $43.81 M   -1.29% 0.86%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 242.86 K $42.87 M   -1.35% 0.84%
MORGAN STANLEY 11/14/2025 234.58 K $41.41 M   0.07% 0.81%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 202.59 K $35.76 M   -13.54% 0.70%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 200.00 K $35.31 M   0.00% 0.69%
NUVEEN, LLC 11/12/2025 197.38 K $34.84 M   4.98% 0.68%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 196.90 K $34.76 M   50.84% 0.68%
BANK OF NEW YORK MELLON CORP 11/03/2025 155.55 K $27.46 M   -3.09% 0.54%
WOODLINE PARTNERS LP 11/14/2025 150.62 K $26.59 M   0.00% 0.52%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 11/12/2025 149.30 K $26.36 M   63.89% 0.52%
MILLENNIUM MANAGEMENT LLC 11/14/2025 148.71 K $26.25 M   1,083.83% 0.51%
UBS GROUP AG 11/13/2025 148.50 K $26.21 M   184.48% 0.51%
JPMORGAN CHASE & CO 11/26/2025 146.35 K $25.84 M   60.56% 0.51%
PRINCIPAL FINANCIAL GROUP INC 11/04/2025 142.84 K $25.22 M   1.39% 0.49%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 142.50 K $25.16 M   19.35% 0.49%
BANK OF AMERICA CORP /DE/ 11/14/2025 138.00 K $24.36 M   13.29% 0.48%
UBS GROUP AG 11/13/2025 130.17 K $22.98 M   33.87% 0.45%
MARSHALL WACE, LLP 11/13/2025 128.96 K $22.77 M   14.75% 0.45%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 11/07/2025 118.51 K $20.92 M   3.77% 0.41%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 113.80 K $20.09 M   -39.76% 0.39%
S SQUARED TECHNOLOGY, LLC 11/14/2025 109.22 K $19.28 M   0.00% 0.38%
ORBIMED ADVISORS LLC 11/14/2025 102.75 K $18.14 M   1,016.79% 0.36%
PUBLIC SECTOR PENSION INVESTMENT BOARD 11/06/2025 100.43 K $17.73 M   15.85% 0.35%
CAPTION MANAGEMENT, LLC 11/14/2025 100.00 K $17.65 M   -16.67% 0.35%
VOYA INVESTMENT MANAGEMENT LLC 10/09/2025 93.91 K $16.58 M   46.75% 0.32%
C WORLDWIDE GROUP HOLDING A/S 11/05/2025 85.81 K $15.15 M   0.00% 0.30%
SEGALL BRYANT & HAMILL, LLC 11/12/2025 85.26 K $15.05 M   -42.63% 0.29%
BARCLAYS PLC 11/12/2025 75.90 K $13.40 M   -18.28% 0.26%
RHUMBLINE ADVISERS 11/06/2025 70.55 K $12.45 M   -0.28% 0.24%
READYSTATE ASSET MANAGEMENT LP 11/07/2025 70.35 K $12.42 M   -52.46% 0.24%
INVESCO LTD. 11/13/2025 66.88 K $11.81 M   -5.65% 0.23%
HANDELSBANKEN FONDER AB 11/12/2025 66.80 K $11.79 M   0.00% 0.23%
LEGAL & GENERAL GROUP PLC 11/13/2025 65.82 K $11.62 M   -3.77% 0.23%

Krystal Biotech, Inc. institutional Ownership - FAQ's

During the previous two years, 356 institutional investors and hedge funds held shares of Krystal Biotech, Inc.. The most heavily invested institutionals were:

FMR LLC: 4.34 M

BlackRock, Inc.: 3.83 M

VANGUARD GROUP INC: 2.79 M

Avoro Capital Advisors LLC: 2.78 M

STATE STREET CORP: 1.4 M

Soleus Capital Management, L.P.: 1.02 M

96.88% of Krystal Biotech, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 34.28 M shares in the last 24 months. This purchase volume represents approximately $7.61 B in transactions.